Document is current
Any future updates will be listed below
-
Authors
Zhang, Fan
Peng, Danyang
He, Faming
Liu, Ying
Zang, Binbin
Gao, Yanqiu
Qin, Chao
Guo, Suping
Qi, Yawei
Zheng, Xisheng
Guo, Lin
Zhao, Tingting
Jin, Yue
Su, Rongqi
Du, Juan
Pan, Jiazhan
Qin, Bingyu
Shao, Huanzhang https://orcid.org/0009-0008-7344-1807
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2100044866 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Colistin Sulfate-Based Combination Therapy for Infections Caused by Carbapenem-Resistant Organisms in Intensive Care Units: A Multicenter, Prospective, Observational Clinical Trial
https://doi.org/10.1007/s40121-025-01176-5
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Henan Province (202300410458)
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 30 May 2025
First Online: 29 June 2025
Declarations
:
: Fan Zhang, Danyang Peng, Faming He, Ying Liu, Binbin Zang, Yanqiu Gao, Chao Qin, Suping Gao, Yawei Qi, Xisheng Zheng, Lin Guo, Tingting Zhao, Yue Jin, Rongqi Su, Juan Du, Jiazhan Pan, Bingyu Qin, and Huanzhang Shao declare no competing interests.
: The study protocol was approved by the Research Ethics Committee of Henan Provincial People’s Hospital [(2021) Ethical Review New Technology (no. 86)] and adhered to Declaration of Helsinki (2013), Good Clinical Practice, and applicable regulations. Nine other institutions approved the protocol, and written informed consent to participate was obtained from all participants.
